Scarica l'app Stockscreener
50.01
0.04%
0.02
Dopo l'orario di chiusura:
50.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$49.99
Aprire:
$49.58
Volume 24 ore:
460.59K
Relative Volume:
0.48
Capitalizzazione di mercato:
$2.41B
Reddito:
$1.35B
Utile/perdita netta:
$163.34M
Rapporto P/E:
15.26
EPS:
3.2763
Flusso di cassa netto:
$189.17M
1 W Prestazione:
-2.44%
1M Prestazione:
+2.61%
6M Prestazione:
-20.64%
1 anno Prestazione:
-29.72%
Intervallo 1D:
$49.00
$50.34
Intervallo di 1 settimana:
$48.98
$51.91
Portata 52W:
$47.31
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Nome
Haemonetics Corp
Settore
Industria
Telefono
(781) 848-7100
Indirizzo
125 SUMMER STREET, BOSTON, MA
Confronta HAE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
50.01 | 2.41B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Reiterato | Barrington Research | Outperform |
| 2025-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-06-26 | Iniziato | Robert W. Baird | Outperform |
| 2025-02-07 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Iniziato | JP Morgan | Overweight |
| 2024-11-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Iniziato | CL King | Buy |
| 2024-09-11 | Iniziato | BofA Securities | Neutral |
| 2024-09-10 | Iniziato | BTIG Research | Buy |
| 2024-06-12 | Aggiornamento | Needham | Hold → Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-01-27 | Downgrade | Needham | Buy → Hold |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Ripresa | Raymond James | Outperform |
| 2021-06-17 | Iniziato | Citigroup | Buy |
| 2021-05-14 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Iniziato | Needham | Buy |
| 2019-08-07 | Reiterato | Barrington Research | Outperform |
| 2019-05-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Reiterato | Barrington Research | Outperform |
| 2018-08-09 | Reiterato | Barrington Research | Outperform |
| 2018-02-07 | Reiterato | Barrington Research | Outperform |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Reiterato | Barrington Research | Outperform |
| 2017-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Reiterato | The Benchmark Company | Hold |
| 2016-09-20 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Downgrade | Sidoti | Buy → Neutral |
| 2016-08-02 | Reiterato | Jefferies | Buy |
| 2016-08-02 | Reiterato | The Benchmark Company | Hold |
Mostra tutto
Haemonetics Corp Borsa (HAE) Ultime notizie
Can Haemonetics Corporation (HAZ) stock test all time highsJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
How Haemonetics Corporation stock benefits from digital adoptionJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Haemonetics (HAE) to Release Earnings on Thursday - MarketBeat
Using RSI to spot recovery in Haemonetics Corporation2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is Haemonetics Corporation (HAZ) stock prepared for digital transitionMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Will Haemonetics Corporation (HAZ) stock issue positive guidanceMarket Trend Report & Free Technical Confirmation Trade Alerts - newser.com
Is Haemonetics Corporation stock a defensive play in 2025Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
How Recent Developments Are Shaping the Haemonetics Investment Story - Yahoo Finance
Using data filters to optimize entry into Haemonetics CorporationQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - newser.com
Can Haemonetics Corporation stock weather global recessionEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Using AI based signals to follow Haemonetics CorporationTrade Exit Report & Safe Entry Zone Identification - newser.com
Is Haemonetics Corporation stock dividend growth reliableJuly 2025 Reactions & Verified Swing Trading Watchlist - newser.com
Can Haemonetics Corporation stock outperform in 2025 bull marketEarnings Performance Report & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Will Haemonetics Corporation stock outperform value stocks2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
What the charts say about Haemonetics Corporation todayWeekly Trend Recap & Technical Confirmation Alerts - newser.com
Will Haemonetics Corporation (HAZ) stock sustain bullish trend into 2025Market Performance Recap & Consistent Profit Alerts - newser.com
Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Riverwater Partners LLC Sells 5,091 Shares of Haemonetics Corporation $HAE - MarketBeat
Does Haemonetics Corporation fit your quant trading modelJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com
When is the best time to exit Haemonetics CorporationTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Haemonetics Corp Azioni (HAE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):